FYERS
Sunil Healthcare73.64
+0.00 (+0.00%)

Sunil Healthcare Share Price

73.64+0.00 (+0.00%)
-9.44% past 1 Year

Corporate filings & documents

Announcements

Book Closure period from 22nd September to 28th September 2026 for the purpose of 52nd AGM of the Company to be held on 28th September 2026 at 12.30 p.m. through VC/OAVM and Cut off date is 21st September 2026 for the purpose of Remote E-voting to start from 9.00 am of 25th September 2026 upto 5 p.m. of 27th September 2026.
1 week ago
Book Closure period from 22nd September to 28th September 2026 for the purpose of 52nd AGM of the Company to be held on 28th September 2026 at 12.30 p.m. through VC/OAVM and Cut off date is 21st September 2026 for the purpose of Remote E-voting to start from 9.00 am of 25th September 2026 upto 5 p.m. of 27th September 2026.
1 week ago
Copy of newspaper publications about dispatch of 52nd AGM Notice and Annual Report 2025-26 to shareholders of Company including book closure intimation etc.
2 weeks ago
Copy of newspaper publications about dispatch of 52nd AGM Notice and Annual Report 2025-26 to shareholders of Company including book closure intimation etc.
2 weeks ago
Annual Report for the FY 2025-26
2 weeks ago
Annual Report for the FY 2025-26
2 weeks ago
Notice of 52nd Annual General Meeting of the Company . Remote-E-voting/E-voting and other information
2 weeks ago
Notice of 52nd Annual General Meeting of the Company . Remote-E-voting/E-voting and other information
2 weeks ago
Publication of notice in newspaper for updation of email id and enabling temporary facility for updation of email Id by shareholders with Evoting agency/ Video Conferencing agency for ensuing 52nd AGM of Company
1 month ago
Publication of notice in newspaper for updation of email id and enabling temporary facility for updation of email Id by shareholders with Evoting agency/ Video Conferencing agency for ensuing 52nd AGM of Company
1 month ago
Copy of Newspaper publication of Un-audited financial results (both standalone and consolidated) for the quarter ended 30th June 2026
1 month ago
Copy of Newspaper publication of Un-audited financial results (both standalone and consolidated) for the quarter ended 30th June 2026
1 month ago
Outcome of Board meeting held on 13th August 2026
1 month ago
Outcome of Board meeting held on 13th August 2026
1 month ago
approved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.2026
1 month ago
approved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.2026
1 month ago
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Board Meeting scheduled to be held on 13.08.2026 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30 2026.
1 month ago
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Board Meeting scheduled to be held on 13.08.2026 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30 2026.
1 month ago
Compliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations
2 months ago
Compliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations
2 months ago
Special window for Transfer and Dematerialisation of Physical Securities
2 months ago
Special window for Transfer and Dematerialisation of Physical Securities
2 months ago
Trading Window Closure Notice for the declaration of Un-audited financial results of the Company for the 1st quarter of FY 2026-27 ended on 30.06.2026
2 months ago
Trading Window Closure Notice for the declaration of Un-audited financial results of the Company for the 1st quarter of FY 2026-27 ended on 30.06.2026
2 months ago
Copy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.206
3 months ago
Copy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.206
3 months ago
Annual Secretarial Compliance Report for the Financial year 2025-26
3 months ago
Annual Secretarial Compliance Report for the Financial year 2025-26
3 months ago
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.2026
3 months ago
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.2026
3 months ago
Outcome of the 269th Board Meeting of the Company held on 29.05.2026
3 months ago
Outcome of the 269th Board Meeting of the Company held on 29.05.2026
3 months ago
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31 2026
3 months ago
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31 2026
3 months ago
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 at Registered office 38E/252A Vijay Tower 3rd Floor Panchsheel Commercial Complex Shahpur Jat New Delhi-110049 (deemed venue) through video conferencing/Audio visual connection inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2025-26 and for the Financial year 2025-26 ended on March 31 2026.
4 months ago
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 at Registered office 38E/252A Vijay Tower 3rd Floor Panchsheel Commercial Complex Shahpur Jat New Delhi-110049 (deemed venue) through video conferencing/Audio visual connection inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2025-26 and for the Financial year 2025-26 ended on March 31 2026.
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sunil Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24302DL1973PLC189662</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>19.08</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SATYENDU PATTNAIK <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PAWAN RATHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 24/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sunil Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24302DL1973PLC189662</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>19.08</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SATYENDU PATTNAIK <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PAWAN RATHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 24/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
Compliance Certificate under Regulation 40(10) of SBI LODR for the year ended 31st March 2026
5 months ago
Compliance Certificate under Regulation 40(10) of SBI LODR for the year ended 31st March 2026
5 months ago
Compliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026
5 months ago
Compliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026
5 months ago
Intimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.2026
5 months ago
Intimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.2026
5 months ago
Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)
7 months ago
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are pleased to inform that the Board of Directors of the Company at their Board Meeting held on Friday February 06 2026 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 3rd quarter/ nine months ended December 31 2025 of the FY 2025-26.
7 months ago
Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26
7 months ago
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on 6th February 2026 to consider interalia un-audited financial results (standalone and consolidated) for the 3rd quarter/9 months ended 31.12.2025 of FY 2025-26
7 months ago
Compliance certificate under Regulation 74(5) of SEBI (DP) regulations 2018 for quarter ended 31.12.2025
8 months ago
Trading window of the Company shall remain close from January 01 2026 till 48 hours after the declaration of the un-audited financial results for the 3rd quarter/nine months of financial year 2025-26 ended on 31st December 2025
8 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Sunil Healthcare Ltd Share Price Today

The Sunil Healthcare Ltd share price today is ₹79.98. During the trading session, the Sunil Healthcare Ltd share price opened at ₹79.98 and recorded an intraday high of ₹79.98 and a low of ₹79.98. Last closing price was ₹79.98. Over the past 52 weeks, the Sunil Healthcare Ltd share price has ranged between ₹67.50 and ₹82.00. The current Sunil Healthcare Ltd stock price reflects real-time market activity based on executed trades on the exchange.